Journal of Bone Oncology: Volume 26 to Volume 31

Spotlight on Journal of Bone Oncology

The Journal of Bone Oncology (JBO) stands as a pioneering publication dedicated to the intersection of bone diseases and cancer. As an open access journal, JBO ensures wide dissemination of its content, promoting greater visibility and accessibility to its high-quality research for the global scientific community.

Here’s what sets JBO apart:

Interdisciplinary Focus: JBO serves as a nexus for researchers and clinicians interested in both oncology and bone diseases, presenting a comprehensive view of how cancer interacts with bone, from bone metastasis to treatment-induced bone loss.

Comprehensive Coverage: The journal addresses a wide array of topics, from the pathophysiology of bone metastases and bone imaging techniques to the development of new bone-targeted therapies and the management of bone pain. This broad scope ensures that readers have access to a diverse range of research areas.

Commitment to Quality: All submissions to JBO undergo rigorous peer review, ensuring that only the most robust, relevant, and impactful research is published. The journal’s inclusion in Clarivate Analytics’ Journal Citation Reports/Science Edition and PubMedCentral attests to its quality and significance in the field.

Diverse Content Types: JBO isn’t limited to just original research articles. It also welcomes review articles, editorials, and opinion pieces, providing a platform for thought leaders to share insights and perspectives. While case reports are considered selectively, they are accompanied by a comprehensive review, ensuring their relevance and depth.

Accessible to All: As an open access journal, JBO ensures that its content is freely accessible to everyone—promoting the democratization of knowledge and facilitating the rapid dissemination of crucial research findings.

Key Topics in Focus: Among the wide-ranging topics JBO covers, the journal delves into the interaction between bone cells and cancer, the development of new drugs targeting bone diseases in cancer patients, the management of bone loss induced by cancer treatments, and the techniques for imaging bone in the context of cancer.

Keywords at a Glance: The keywords associated with the journal – from “osteoblast” and “osteoclast” to “metastasis” and “denosumab” – highlight its multidisciplinary nature, bridging the worlds of oncology and bone research.

In essence, the Journal of Bone Oncology offers an invaluable resource for those at the forefront of bone and cancer research, acting as a bridge between these two crucial fields and driving forward our understanding of how they intersect. Whether you’re a researcher, clinician, or student, JBO promises insights that are both deep and broad.

Volume 26: February 2021

Volume 27: April 2021

Volume 28: June 2021

Volume 29: August 2021

Volume 30: October 2021

Volume 31: December 2021